Annual D&A
$1.70 M
+$217.00 K+14.59%
31 December 2023
Summary:
Apellis Pharmaceuticals annual depreciation & amortization is currently $1.70 million, with the most recent change of +$217.00 thousand (+14.59%) on 31 December 2023. During the last 3 years, it has risen by +$845.00 thousand (+98.37%). APLS annual D&A is now at all-time high.APLS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$621.00 K
+$227.00 K+57.61%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly depreciation & amortization is currently $621.00 thousand, with the most recent change of +$227.00 thousand (+57.61%) on 30 September 2024. Over the past year, it has increased by +$216.00 thousand (+53.33%). APLS quarterly D&A is now at all-time high.APLS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.83 M
+$216.00 K+13.36%
30 September 2024
Summary:
Apellis Pharmaceuticals TTM depreciation & amortization is currently $1.83 million, with the most recent change of +$216.00 thousand (+13.36%) on 30 September 2024. Over the past year, it has increased by +$191.00 thousand (+11.63%). APLS TTM D&A is now at all-time high.APLS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.6% | +53.3% | +11.6% |
| 3 y3 years | +98.4% | +126.6% | +31.3% |
| 5 y5 years | +100.0% | +331.3% | +382.4% |
APLS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.4% | at high | +126.6% | at high | +35.6% |
| 5 y | 5 years | at high | at high | +409.0% | at high | +382.4% | |
| alltime | all time | at high | at high | at high |
Apellis Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $621.00 K(+57.6%) | $1.83 M(+13.4%) |
| June 2024 | - | $394.00 K(+20.1%) | $1.62 M(-1.0%) |
| Mar 2024 | - | $328.00 K(-33.1%) | $1.63 M(-4.2%) |
| Dec 2023 | $1.70 M(+14.6%) | $490.00 K(+21.0%) | $1.70 M(+3.8%) |
| Sept 2023 | - | $405.00 K(-1.2%) | $1.64 M(+3.0%) |
| June 2023 | - | $410.00 K(+2.8%) | $1.59 M(+4.5%) |
| Mar 2023 | - | $399.00 K(-6.8%) | $1.53 M(+2.6%) |
| Dec 2022 | $1.49 M(-0.3%) | $428.00 K(+19.9%) | $1.49 M(+3.6%) |
| Sept 2022 | - | $357.00 K(+4.4%) | $1.44 M(+6.1%) |
| June 2022 | - | $342.00 K(-5.0%) | $1.35 M(-7.3%) |
| Mar 2022 | - | $360.00 K(-4.3%) | $1.46 M(-2.3%) |
| Dec 2021 | $1.49 M(+73.7%) | $376.00 K(+37.2%) | $1.49 M(+6.9%) |
| Sept 2021 | - | $274.00 K(-38.8%) | $1.40 M(-2.9%) |
| June 2021 | - | $448.00 K(+13.7%) | $1.44 M(+29.3%) |
| Mar 2021 | - | $394.00 K(+40.7%) | $1.11 M(+29.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $859.00 K(+44.1%) | $280.00 K(-11.1%) | $859.00 K(+8.1%) |
| Sept 2020 | - | $315.00 K(+158.2%) | $795.00 K(+27.4%) |
| June 2020 | - | $122.00 K(-14.1%) | $624.00 K(0.0%) |
| Mar 2020 | - | $142.00 K(-34.3%) | $624.00 K(+4.7%) |
| Dec 2019 | $596.00 K(>+9900.0%) | $216.00 K(+50.0%) | $596.00 K(+56.8%) |
| Sept 2019 | - | $144.00 K(+18.0%) | $380.00 K(+61.0%) |
| June 2019 | - | $122.00 K(+7.0%) | $236.00 K(+107.0%) |
| Mar 2019 | - | $114.00 K(>+9900.0%) | $114.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Dec 2014 | $6600.00(+4.8%) | - | - |
| Dec 2013 | $6300.00 | - | - |
FAQ
- What is Apellis Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual D&A year-on-year change?
- What is Apellis Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly D&A year-on-year change?
- What is Apellis Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM D&A year-on-year change?
What is Apellis Pharmaceuticals annual depreciation & amortization?
The current annual D&A of APLS is $1.70 M
What is the all time high annual D&A for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual depreciation & amortization is $1.70 M
What is Apellis Pharmaceuticals annual D&A year-on-year change?
Over the past year, APLS annual depreciation & amortization has changed by +$217.00 K (+14.59%)
What is Apellis Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of APLS is $621.00 K
What is the all time high quarterly D&A for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly depreciation & amortization is $621.00 K
What is Apellis Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, APLS quarterly depreciation & amortization has changed by +$216.00 K (+53.33%)
What is Apellis Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of APLS is $1.83 M
What is the all time high TTM D&A for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM depreciation & amortization is $1.83 M
What is Apellis Pharmaceuticals TTM D&A year-on-year change?
Over the past year, APLS TTM depreciation & amortization has changed by +$191.00 K (+11.63%)